id	sid	tid	token	lemma	pos
cord-303183-oya0pdhw	1	1	key	key	JJ
cord-303183-oya0pdhw	1	2	:	:	:
cord-303183-oya0pdhw	1	3	cord-303183-oya0pdhw	cord-303183-oya0pdhw	CD
cord-303183-oya0pdhw	1	4	authors	author	NNS
cord-303183-oya0pdhw	1	5	:	:	:
cord-303183-oya0pdhw	1	6	Bersanelli	Bersanelli	NNP
cord-303183-oya0pdhw	1	7	,	,	,
cord-303183-oya0pdhw	1	8	Melissa	Melissa	NNP
cord-303183-oya0pdhw	1	9	title	title	NN
cord-303183-oya0pdhw	1	10	:	:	:
cord-303183-oya0pdhw	2	1	COVID-19	covid-19	VB
cord-303183-oya0pdhw	2	2	and	and	CC
cord-303183-oya0pdhw	2	3	the	the	DT
cord-303183-oya0pdhw	2	4	newly	newly	RB
cord-303183-oya0pdhw	2	5	rediscovered	rediscover	VBN
cord-303183-oya0pdhw	2	6	multidisciplinarity	multidisciplinarity	NN
cord-303183-oya0pdhw	2	7	date	date	NN
cord-303183-oya0pdhw	2	8	:	:	:
cord-303183-oya0pdhw	2	9	2020	2020	CD
cord-303183-oya0pdhw	2	10	-	-	HYPH
cord-303183-oya0pdhw	2	11	09	09	CD
cord-303183-oya0pdhw	2	12	-	-	SYM
cord-303183-oya0pdhw	2	13	22	22	CD
cord-303183-oya0pdhw	2	14	journal	journal	NN
cord-303183-oya0pdhw	2	15	:	:	:
cord-303183-oya0pdhw	2	16	Immunotherapy	Immunotherapy	NNP
cord-303183-oya0pdhw	2	17	DOI	DOI	NNP
cord-303183-oya0pdhw	2	18	:	:	:
cord-303183-oya0pdhw	2	19	10.2217	10.2217	CD
cord-303183-oya0pdhw	2	20	/	/	SYM
cord-303183-oya0pdhw	2	21	imt-2020	imt-2020	NN
cord-303183-oya0pdhw	2	22	-	-	HYPH
cord-303183-oya0pdhw	2	23	0205	0205	CD
cord-303183-oya0pdhw	3	1	sha	sha	NNP
cord-303183-oya0pdhw	3	2	:	:	:
cord-303183-oya0pdhw	4	1	f874e0ce31e09689b03521f43cfc55fc7d4a77af	f874e0ce31e09689b03521f43cfc55fc7d4a77af	JJ
cord-303183-oya0pdhw	4	2	doc_id	doc_id	CD
cord-303183-oya0pdhw	4	3	:	:	:
cord-303183-oya0pdhw	4	4	303183	303183	CD
cord-303183-oya0pdhw	4	5	cord_uid	cord_uid	NNS
cord-303183-oya0pdhw	4	6	:	:	:
cord-303183-oya0pdhw	5	1	oya0pdhw	oya0pdhw	NNP
cord-303183-oya0pdhw	5	2	nan	nan	NNP
cord-303183-oya0pdhw	6	1	Unfortunately	unfortunately	RB
cord-303183-oya0pdhw	6	2	,	,	,
cord-303183-oya0pdhw	6	3	SARS	SARS	NNP
cord-303183-oya0pdhw	6	4	-	-	HYPH
cord-303183-oya0pdhw	6	5	CoV-2	CoV-2	NNP
cord-303183-oya0pdhw	6	6	infections	infection	NNS
cord-303183-oya0pdhw	6	7	often	often	RB
cord-303183-oya0pdhw	6	8	do	do	VBP
cord-303183-oya0pdhw	6	9	not	not	RB
cord-303183-oya0pdhw	6	10	allow	allow	VB
cord-303183-oya0pdhw	6	11	thoughtful	thoughtful	JJ
cord-303183-oya0pdhw	6	12	reflections	reflection	NNS
cord-303183-oya0pdhw	6	13	on	on	IN
cord-303183-oya0pdhw	6	14	the	the	DT
cord-303183-oya0pdhw	6	15	main	main	JJ
cord-303183-oya0pdhw	6	16	components	component	NNS
cord-303183-oya0pdhw	6	17	of	of	IN
cord-303183-oya0pdhw	6	18	the	the	DT
cord-303183-oya0pdhw	6	19	worsening	worsen	VBG
cord-303183-oya0pdhw	6	20	condition	condition	NN
cord-303183-oya0pdhw	6	21	of	of	IN
cord-303183-oya0pdhw	6	22	the	the	DT
cord-303183-oya0pdhw	6	23	patient	patient	NN
cord-303183-oya0pdhw	6	24	,	,	,
cord-303183-oya0pdhw	6	25	and	and	CC
cord-303183-oya0pdhw	6	26	the	the	DT
cord-303183-oya0pdhw	6	27	emergency	emergency	NN
cord-303183-oya0pdhw	6	28	frequently	frequently	RB
cord-303183-oya0pdhw	6	29	leads	lead	VBZ
cord-303183-oya0pdhw	6	30	to	to	IN
cord-303183-oya0pdhw	6	31	messy	messy	JJ
cord-303183-oya0pdhw	6	32	therapeutic	therapeutic	JJ
cord-303183-oya0pdhw	6	33	solutions	solution	NNS
cord-303183-oya0pdhw	6	34	.	.	.
cord-303183-oya0pdhw	7	1	In	in	IN
cord-303183-oya0pdhw	7	2	the	the	DT
cord-303183-oya0pdhw	7	3	end	end	NN
cord-303183-oya0pdhw	7	4	,	,	,
cord-303183-oya0pdhw	7	5	the	the	DT
cord-303183-oya0pdhw	7	6	same	same	JJ
cord-303183-oya0pdhw	7	7	patient	patient	NN
cord-303183-oya0pdhw	7	8	could	could	MD
cord-303183-oya0pdhw	7	9	have	have	VB
cord-303183-oya0pdhw	7	10	been	be	VBN
cord-303183-oya0pdhw	7	11	treated	treat	VBN
cord-303183-oya0pdhw	7	12	with	with	IN
cord-303183-oya0pdhw	7	13	both	both	DT
cord-303183-oya0pdhw	7	14	immunesuppressants	immunesuppressant	NNS
cord-303183-oya0pdhw	7	15	or	or	CC
cord-303183-oya0pdhw	7	16	immune	immune	NN
cord-303183-oya0pdhw	7	17	-	-	HYPH
cord-303183-oya0pdhw	7	18	enhancers	enhancer	NNS
cord-303183-oya0pdhw	7	19	,	,	,
cord-303183-oya0pdhw	7	20	with	with	IN
cord-303183-oya0pdhw	7	21	the	the	DT
cord-303183-oya0pdhw	7	22	aim	aim	NN
cord-303183-oya0pdhw	7	23	of	of	IN
cord-303183-oya0pdhw	7	24	timely	timely	RB
cord-303183-oya0pdhw	7	25	intercept	intercept	NN
cord-303183-oya0pdhw	7	26	of	of	IN
cord-303183-oya0pdhw	7	27	the	the	DT
cord-303183-oya0pdhw	7	28	upcoming	upcoming	JJ
cord-303183-oya0pdhw	7	29	phase	phase	NN
cord-303183-oya0pdhw	7	30	of	of	IN
cord-303183-oya0pdhw	7	31	the	the	DT
cord-303183-oya0pdhw	7	32	disease	disease	NN
cord-303183-oya0pdhw	7	33	.	.	.
cord-303183-oya0pdhw	8	1	If	if	IN
cord-303183-oya0pdhw	8	2	the	the	DT
cord-303183-oya0pdhw	8	3	cruciality	cruciality	NN
cord-303183-oya0pdhw	8	4	of	of	IN
cord-303183-oya0pdhw	8	5	the	the	DT
cord-303183-oya0pdhw	8	6	immune	immune	JJ
cord-303183-oya0pdhw	8	7	response	response	NN
cord-303183-oya0pdhw	8	8	in	in	IN
cord-303183-oya0pdhw	8	9	COVID-19	covid-19	JJ
cord-303183-oya0pdhw	8	10	pathogenesis	pathogenesis	NN
cord-303183-oya0pdhw	8	11	is	be	VBZ
cord-303183-oya0pdhw	8	12	out	out	IN
cord-303183-oya0pdhw	8	13	of	of	IN
cord-303183-oya0pdhw	8	14	the	the	DT
cord-303183-oya0pdhw	8	15	question	question	NN
cord-303183-oya0pdhw	8	16	,	,	,
cord-303183-oya0pdhw	8	17	it	-PRON-	PRP
cord-303183-oya0pdhw	8	18	is	be	VBZ
cord-303183-oya0pdhw	8	19	still	still	RB
cord-303183-oya0pdhw	8	20	unclear	unclear	JJ
cord-303183-oya0pdhw	8	21	if	if	IN
cord-303183-oya0pdhw	8	22	the	the	DT
cord-303183-oya0pdhw	8	23	morbidity	morbidity	NN
cord-303183-oya0pdhw	8	24	could	could	MD
cord-303183-oya0pdhw	8	25	be	be	VB
cord-303183-oya0pdhw	8	26	more	more	RBR
cord-303183-oya0pdhw	8	27	due	due	IN
cord-303183-oya0pdhw	8	28	to	to	IN
cord-303183-oya0pdhw	8	29	an	an	DT
cord-303183-oya0pdhw	8	30	initial	initial	JJ
cord-303183-oya0pdhw	8	31	immune	immune	JJ
cord-303183-oya0pdhw	8	32	-	-	HYPH
cord-303183-oya0pdhw	8	33	suppressive	suppressive	JJ
cord-303183-oya0pdhw	8	34	vulnerability	vulnerability	NN
cord-303183-oya0pdhw	8	35	or	or	CC
cord-303183-oya0pdhw	8	36	,	,	,
cord-303183-oya0pdhw	8	37	on	on	IN
cord-303183-oya0pdhw	8	38	the	the	DT
cord-303183-oya0pdhw	8	39	contrary	contrary	NN
cord-303183-oya0pdhw	8	40	,	,	,
cord-303183-oya0pdhw	8	41	to	to	IN
cord-303183-oya0pdhw	8	42	a	a	DT
cord-303183-oya0pdhw	8	43	late	late	JJ
cord-303183-oya0pdhw	8	44	and	and	CC
cord-303183-oya0pdhw	8	45	aberrant	aberrant	JJ
cord-303183-oya0pdhw	8	46	immune	immune	JJ
cord-303183-oya0pdhw	8	47	hyperactivation	hyperactivation	NN
cord-303183-oya0pdhw	8	48	.	.	.
cord-303183-oya0pdhw	9	1	The	the	DT
cord-303183-oya0pdhw	9	2	reports	report	NNS
cord-303183-oya0pdhw	9	3	published	publish	VBN
cord-303183-oya0pdhw	9	4	in	in	IN
cord-303183-oya0pdhw	9	5	the	the	DT
cord-303183-oya0pdhw	9	6	present	present	JJ
cord-303183-oya0pdhw	9	7	issue	issue	NN
cord-303183-oya0pdhw	9	8	,	,	,
cord-303183-oya0pdhw	9	9	aside	aside	RB
cord-303183-oya0pdhw	9	10	from	from	IN
cord-303183-oya0pdhw	9	11	contributing	contribute	VBG
cord-303183-oya0pdhw	9	12	to	to	IN
cord-303183-oya0pdhw	9	13	a	a	DT
cord-303183-oya0pdhw	9	14	valuable	valuable	JJ
cord-303183-oya0pdhw	9	15	brainstorming	brainstorming	NN
cord-303183-oya0pdhw	9	16	on	on	IN
cord-303183-oya0pdhw	9	17	the	the	DT
cord-303183-oya0pdhw	9	18	underlying	underlie	VBG
cord-303183-oya0pdhw	9	19	biological	biological	JJ
cord-303183-oya0pdhw	9	20	mechanisms	mechanism	NNS
cord-303183-oya0pdhw	9	21	to	to	TO
cord-303183-oya0pdhw	9	22	exploit	exploit	VB
cord-303183-oya0pdhw	9	23	for	for	IN
cord-303183-oya0pdhw	9	24	COVID-19	covid-19	JJ
cord-303183-oya0pdhw	9	25	recovery	recovery	NN
cord-303183-oya0pdhw	9	26	,	,	,
cord-303183-oya0pdhw	9	27	represent	represent	VB
cord-303183-oya0pdhw	9	28	the	the	DT
cord-303183-oya0pdhw	9	29	testimony	testimony	NN
cord-303183-oya0pdhw	9	30	of	of	IN
cord-303183-oya0pdhw	9	31	the	the	DT
cord-303183-oya0pdhw	9	32	complicated	complicated	JJ
cord-303183-oya0pdhw	9	33	rationale	rationale	NN
cord-303183-oya0pdhw	9	34	behind	behind	IN
cord-303183-oya0pdhw	9	35	the	the	DT
cord-303183-oya0pdhw	9	36	current	current	JJ
cord-303183-oya0pdhw	9	37	therapeutic	therapeutic	JJ
cord-303183-oya0pdhw	9	38	approaches	approach	NNS
cord-303183-oya0pdhw	9	39	to	to	IN
cord-303183-oya0pdhw	9	40	the	the	DT
cord-303183-oya0pdhw	9	41	disease	disease	NN
cord-303183-oya0pdhw	9	42	.	.	.
cord-303183-oya0pdhw	10	1	If	if	IN
cord-303183-oya0pdhw	10	2	the	the	DT
cord-303183-oya0pdhw	10	3	use	use	NN
cord-303183-oya0pdhw	10	4	of	of	IN
cord-303183-oya0pdhw	10	5	tocilizumab	tocilizumab	NNP
cord-303183-oya0pdhw	10	6	still	still	RB
cord-303183-oya0pdhw	10	7	emerges	emerge	VBZ
cord-303183-oya0pdhw	10	8	as	as	IN
cord-303183-oya0pdhw	10	9	one	one	CD
cord-303183-oya0pdhw	10	10	of	of	IN
cord-303183-oya0pdhw	10	11	the	the	DT
cord-303183-oya0pdhw	10	12	most	most	RBS
cord-303183-oya0pdhw	10	13	promising	promising	JJ
cord-303183-oya0pdhw	10	14	solutions	solution	NNS
cord-303183-oya0pdhw	10	15	,	,	,
cord-303183-oya0pdhw	10	16	supported	support	VBN
cord-303183-oya0pdhw	10	17	by	by	IN
cord-303183-oya0pdhw	10	18	scarce	scarce	JJ
cord-303183-oya0pdhw	10	19	prospective	prospective	JJ
cord-303183-oya0pdhw	10	20	evidence	evidence	NN
cord-303183-oya0pdhw	10	21	but	but	CC
cord-303183-oya0pdhw	10	22	pushed	push	VBN
cord-303183-oya0pdhw	10	23	by	by	IN
cord-303183-oya0pdhw	10	24	the	the	DT
cord-303183-oya0pdhw	10	25	unmet	unmet	JJ
cord-303183-oya0pdhw	10	26	need	need	NN
cord-303183-oya0pdhw	10	27	of	of	IN
cord-303183-oya0pdhw	10	28	an	an	DT
cord-303183-oya0pdhw	10	29	effective	effective	JJ
cord-303183-oya0pdhw	10	30	treatment	treatment	NN
cord-303183-oya0pdhw	10	31	[	[	-LRB-
cord-303183-oya0pdhw	10	32	1	1	CD
cord-303183-oya0pdhw	10	33	,	,	,
cord-303183-oya0pdhw	10	34	6	6	CD
cord-303183-oya0pdhw	10	35	]	]	-RRB-
cord-303183-oya0pdhw	10	36	,	,	,
cord-303183-oya0pdhw	10	37	the	the	DT
cord-303183-oya0pdhw	10	38	attempt	attempt	NN
cord-303183-oya0pdhw	10	39	to	to	TO
cord-303183-oya0pdhw	10	40	outflank	outflank	VB
cord-303183-oya0pdhw	10	41	the	the	DT
cord-303183-oya0pdhw	10	42	immune	immune	JJ
cord-303183-oya0pdhw	10	43	system	system	NN
cord-303183-oya0pdhw	10	44	suppression	suppression	NN
cord-303183-oya0pdhw	10	45	has	have	VBZ
cord-303183-oya0pdhw	10	46	led	lead	VBN
cord-303183-oya0pdhw	10	47	to	to	IN
cord-303183-oya0pdhw	10	48	the	the	DT
cord-303183-oya0pdhw	10	49	proposal	proposal	NN
cord-303183-oya0pdhw	10	50	of	of	IN
cord-303183-oya0pdhw	10	51	an	an	DT
cord-303183-oya0pdhw	10	52	immuneprotection	immuneprotection	NN
cord-303183-oya0pdhw	10	53	,	,	,
cord-303183-oya0pdhw	10	54	exploiting	exploit	VBG
cord-303183-oya0pdhw	10	55	physiological	physiological	JJ
cord-303183-oya0pdhw	10	56	checkpoints	checkpoint	NNS
cord-303183-oya0pdhw	10	57	to	to	TO
cord-303183-oya0pdhw	10	58	restore	restore	VB
cord-303183-oya0pdhw	10	59	the	the	DT
cord-303183-oya0pdhw	10	60	immunocompetence	immunocompetence	NN
cord-303183-oya0pdhw	10	61	[	[	-LRB-
cord-303183-oya0pdhw	10	62	3	3	CD
cord-303183-oya0pdhw	10	63	]	]	-RRB-
cord-303183-oya0pdhw	10	64	.	.	.
cord-303183-oya0pdhw	11	1	It	-PRON-	PRP
cord-303183-oya0pdhw	11	2	is	be	VBZ
cord-303183-oya0pdhw	11	3	the	the	DT
cord-303183-oya0pdhw	11	4	same	same	JJ
cord-303183-oya0pdhw	11	5	rationale	rationale	NN
cord-303183-oya0pdhw	11	6	behind	behind	IN
cord-303183-oya0pdhw	11	7	the	the	DT
cord-303183-oya0pdhw	11	8	immunotherapy	immunotherapy	NN
cord-303183-oya0pdhw	11	9	of	of	IN
cord-303183-oya0pdhw	11	10	cancers	cancer	NNS
cord-303183-oya0pdhw	11	11	,	,	,
cord-303183-oya0pdhw	11	12	recently	recently	RB
cord-303183-oya0pdhw	11	13	revolutionizing	revolutionize	VBG
cord-303183-oya0pdhw	11	14	the	the	DT
cord-303183-oya0pdhw	11	15	therapeutic	therapeutic	JJ
cord-303183-oya0pdhw	11	16	approach	approach	NN
cord-303183-oya0pdhw	11	17	to	to	IN
cord-303183-oya0pdhw	11	18	solid	solid	JJ
cord-303183-oya0pdhw	11	19	tumors	tumor	NNS
cord-303183-oya0pdhw	11	20	from	from	IN
cord-303183-oya0pdhw	11	21	an	an	DT
cord-303183-oya0pdhw	11	22	immunosuppressive	immunosuppressive	JJ
cord-303183-oya0pdhw	11	23	perspective	perspective	NN
cord-303183-oya0pdhw	11	24	(	(	-LRB-
cord-303183-oya0pdhw	11	25	e.g.	e.g.	RB
cord-303183-oya0pdhw	11	26	,	,	,
cord-303183-oya0pdhw	11	27	chemotherapy	chemotherapy	NN
cord-303183-oya0pdhw	11	28	)	)	-RRB-
cord-303183-oya0pdhw	11	29	to	to	IN
cord-303183-oya0pdhw	11	30	an	an	DT
cord-303183-oya0pdhw	11	31	immunerestoring	immunerestore	VBG
cord-303183-oya0pdhw	11	32	attempt	attempt	NN
cord-303183-oya0pdhw	11	33	[	[	-LRB-
cord-303183-oya0pdhw	11	34	9	9	CD
cord-303183-oya0pdhw	11	35	]	]	-RRB-
cord-303183-oya0pdhw	11	36	.	.	.
cord-303183-oya0pdhw	12	1	The	the	DT
cord-303183-oya0pdhw	12	2	switch	switch	NN
cord-303183-oya0pdhw	12	3	is	be	VBZ
cord-303183-oya0pdhw	12	4	difficult	difficult	JJ
cord-303183-oya0pdhw	12	5	to	to	TO
cord-303183-oya0pdhw	12	6	accept	accept	VB
cord-303183-oya0pdhw	12	7	,	,	,
cord-303183-oya0pdhw	12	8	but	but	CC
cord-303183-oya0pdhw	12	9	in	in	IN
cord-303183-oya0pdhw	12	10	the	the	DT
cord-303183-oya0pdhw	12	11	case	case	NN
cord-303183-oya0pdhw	12	12	of	of	IN
cord-303183-oya0pdhw	12	13	oncology	oncology	NN
cord-303183-oya0pdhw	12	14	the	the	DT
cord-303183-oya0pdhw	12	15	clinical	clinical	JJ
cord-303183-oya0pdhw	12	16	evidence	evidence	NN
cord-303183-oya0pdhw	12	17	strongly	strongly	RB
cord-303183-oya0pdhw	12	18	advocates	advocate	VBZ
cord-303183-oya0pdhw	12	19	the	the	DT
cord-303183-oya0pdhw	12	20	newest	new	JJS
cord-303183-oya0pdhw	12	21	approach	approach	NN
cord-303183-oya0pdhw	12	22	,	,	,
cord-303183-oya0pdhw	12	23	likely	likely	RB
cord-303183-oya0pdhw	12	24	the	the	DT
cord-303183-oya0pdhw	12	25	most	most	RBS
cord-303183-oya0pdhw	12	26	physiological	physiological	JJ
cord-303183-oya0pdhw	12	27	,	,	,
cord-303183-oya0pdhw	12	28	relying	rely	VBG
cord-303183-oya0pdhw	12	29	more	more	RBR
cord-303183-oya0pdhw	12	30	on	on	IN
cord-303183-oya0pdhw	12	31	the	the	DT
cord-303183-oya0pdhw	12	32	normalization	normalization	NN
cord-303183-oya0pdhw	12	33	than	than	IN
cord-303183-oya0pdhw	12	34	on	on	IN
cord-303183-oya0pdhw	12	35	the	the	DT
cord-303183-oya0pdhw	12	36	enhancement	enhancement	NN
cord-303183-oya0pdhw	12	37	of	of	IN
cord-303183-oya0pdhw	12	38	the	the	DT
cord-303183-oya0pdhw	12	39	immunological	immunological	JJ
cord-303183-oya0pdhw	12	40	status	status	NN
cord-303183-oya0pdhw	12	41	[	[	-LRB-
cord-303183-oya0pdhw	12	42	10	10	CD
cord-303183-oya0pdhw	12	43	]	]	-RRB-
cord-303183-oya0pdhw	12	44	.	.	.
cord-303183-oya0pdhw	13	1	Indeed	indeed	RB
cord-303183-oya0pdhw	13	2	,	,	,
cord-303183-oya0pdhw	13	3	the	the	DT
cord-303183-oya0pdhw	13	4	immune	immune	JJ
cord-303183-oya0pdhw	13	5	checkpoint	checkpoint	NN
cord-303183-oya0pdhw	13	6	blockade	blockade	NN
cord-303183-oya0pdhw	13	7	limits	limit	VBZ
cord-303183-oya0pdhw	13	8	its	-PRON-	PRP$
cord-303183-oya0pdhw	13	9	effects	effect	NNS
cord-303183-oya0pdhw	13	10	in	in	IN
cord-303183-oya0pdhw	13	11	removing	remove	VBG
cord-303183-oya0pdhw	13	12	a	a	DT
cord-303183-oya0pdhw	13	13	block	block	NN
cord-303183-oya0pdhw	13	14	,	,	,
cord-303183-oya0pdhw	13	15	allowing	allow	VBG
cord-303183-oya0pdhw	13	16	normal	normal	JJ
cord-303183-oya0pdhw	13	17	operation	operation	NN
cord-303183-oya0pdhw	13	18	of	of	IN
cord-303183-oya0pdhw	13	19	the	the	DT
cord-303183-oya0pdhw	13	20	immune	immune	JJ
cord-303183-oya0pdhw	13	21	system	system	NN
cord-303183-oya0pdhw	13	22	to	to	TO
cord-303183-oya0pdhw	13	23	resume	resume	VB
cord-303183-oya0pdhw	13	24	,	,	,
cord-303183-oya0pdhw	13	25	more	more	JJR
cord-303183-oya0pdhw	13	26	than	than	IN
cord-303183-oya0pdhw	13	27	enhancing	enhance	VBG
cord-303183-oya0pdhw	13	28	the	the	DT
cord-303183-oya0pdhw	13	29	immune	immune	JJ
cord-303183-oya0pdhw	13	30	activation	activation	NN
cord-303183-oya0pdhw	13	31	,	,	,
cord-303183-oya0pdhw	13	32	that	that	WDT
cord-303183-oya0pdhw	13	33	could	could	MD
cord-303183-oya0pdhw	13	34	even	even	RB
cord-303183-oya0pdhw	13	35	be	be	VB
cord-303183-oya0pdhw	13	36	harmful	harmful	JJ
cord-303183-oya0pdhw	13	37	in	in	IN
cord-303183-oya0pdhw	13	38	the	the	DT
cord-303183-oya0pdhw	13	39	context	context	NN
cord-303183-oya0pdhw	13	40	of	of	IN
cord-303183-oya0pdhw	13	41	severe	severe	JJ
cord-303183-oya0pdhw	13	42	COVID-19	covid-19	NN
cord-303183-oya0pdhw	13	43	.	.	.
cord-303183-oya0pdhw	14	1	Aside	aside	RB
cord-303183-oya0pdhw	14	2	from	from	IN
cord-303183-oya0pdhw	14	3	the	the	DT
cord-303183-oya0pdhw	14	4	treatment	treatment	NN
cord-303183-oya0pdhw	14	5	of	of	IN
cord-303183-oya0pdhw	14	6	the	the	DT
cord-303183-oya0pdhw	14	7	SARS	SARS	NNP
cord-303183-oya0pdhw	14	8	-	-	HYPH
cord-303183-oya0pdhw	14	9	CoV-2	CoV-2	NNP
cord-303183-oya0pdhw	14	10	infection	infection	NN
cord-303183-oya0pdhw	14	11	,	,	,
cord-303183-oya0pdhw	14	12	primary	primary	JJ
cord-303183-oya0pdhw	14	13	and	and	CC
cord-303183-oya0pdhw	14	14	secondary	secondary	JJ
cord-303183-oya0pdhw	14	15	prevention	prevention	NN
cord-303183-oya0pdhw	14	16	is	be	VBZ
cord-303183-oya0pdhw	14	17	an	an	DT
cord-303183-oya0pdhw	14	18	incredibly	incredibly	RB
cord-303183-oya0pdhw	14	19	important	important	JJ
cord-303183-oya0pdhw	14	20	concern	concern	NN
cord-303183-oya0pdhw	14	21	,	,	,
cord-303183-oya0pdhw	14	22	especially	especially	RB
cord-303183-oya0pdhw	14	23	in	in	IN
cord-303183-oya0pdhw	14	24	frail	frail	JJ
cord-303183-oya0pdhw	14	25	populations	population	NNS
cord-303183-oya0pdhw	14	26	such	such	JJ
cord-303183-oya0pdhw	14	27	as	as	IN
cord-303183-oya0pdhw	14	28	those	those	DT
cord-303183-oya0pdhw	14	29	affected	affect	VBN
cord-303183-oya0pdhw	14	30	by	by	IN
cord-303183-oya0pdhw	14	31	cancer	cancer	NN
cord-303183-oya0pdhw	14	32	,	,	,
cord-303183-oya0pdhw	14	33	hematologic	hematologic	JJ
cord-303183-oya0pdhw	14	34	malignancies	malignancy	NNS
cord-303183-oya0pdhw	14	35	,	,	,
cord-303183-oya0pdhw	14	36	obesity	obesity	NN
cord-303183-oya0pdhw	14	37	,	,	,
cord-303183-oya0pdhw	14	38	pulmonary	pulmonary	JJ
cord-303183-oya0pdhw	14	39	chronic	chronic	JJ
cord-303183-oya0pdhw	14	40	obstructive	obstructive	JJ
cord-303183-oya0pdhw	14	41	disease	disease	NN
cord-303183-oya0pdhw	14	42	,	,	,
cord-303183-oya0pdhw	14	43	cardiovascular	cardiovascular	JJ
cord-303183-oya0pdhw	14	44	diseases	disease	NNS
cord-303183-oya0pdhw	14	45	or	or	CC
cord-303183-oya0pdhw	14	46	metabolic	metabolic	JJ
cord-303183-oya0pdhw	14	47	disorders	disorder	NNS
cord-303183-oya0pdhw	14	48	[	[	-LRB-
cord-303183-oya0pdhw	14	49	2	2	CD
cord-303183-oya0pdhw	14	50	]	]	-RRB-
cord-303183-oya0pdhw	14	51	[	[	-LRB-
cord-303183-oya0pdhw	14	52	3	3	CD
cord-303183-oya0pdhw	14	53	]	]	-RRB-
cord-303183-oya0pdhw	14	54	[	[	-LRB-
cord-303183-oya0pdhw	14	55	4	4	CD
cord-303183-oya0pdhw	14	56	]	]	-RRB-
cord-303183-oya0pdhw	14	57	[	[	-LRB-
cord-303183-oya0pdhw	14	58	5	5	CD
cord-303183-oya0pdhw	14	59	]	]	-RRB-
cord-303183-oya0pdhw	14	60	8	8	CD
cord-303183-oya0pdhw	14	61	]	]	-RRB-
cord-303183-oya0pdhw	14	62	.	.	.
cord-303183-oya0pdhw	15	1	The	the	DT
cord-303183-oya0pdhw	15	2	first	first	JJ
cord-303183-oya0pdhw	15	3	tool	tool	NN
cord-303183-oya0pdhw	15	4	to	to	TO
cord-303183-oya0pdhw	15	5	be	be	VB
cord-303183-oya0pdhw	15	6	exploited	exploit	VBN
cord-303183-oya0pdhw	15	7	for	for	IN
cord-303183-oya0pdhw	15	8	prevention	prevention	NN
cord-303183-oya0pdhw	15	9	is	be	VBZ
cord-303183-oya0pdhw	15	10	knowledge	knowledge	NN
cord-303183-oya0pdhw	15	11	:	:	:
cord-303183-oya0pdhw	15	12	an	an	DT
cord-303183-oya0pdhw	15	13	accurate	accurate	JJ
cord-303183-oya0pdhw	15	14	epidemiological	epidemiological	JJ
cord-303183-oya0pdhw	15	15	framework	framework	NN
cord-303183-oya0pdhw	15	16	of	of	IN
cord-303183-oya0pdhw	15	17	the	the	DT
cord-303183-oya0pdhw	15	18	disease	disease	NN
cord-303183-oya0pdhw	15	19	in	in	IN
cord-303183-oya0pdhw	15	20	frail	frail	JJ
cord-303183-oya0pdhw	15	21	populations	population	NNS
cord-303183-oya0pdhw	15	22	is	be	VBZ
cord-303183-oya0pdhw	15	23	unfortunately	unfortunately	RB
cord-303183-oya0pdhw	15	24	still	still	RB
cord-303183-oya0pdhw	15	25	missing	miss	VBG
cord-303183-oya0pdhw	15	26	,	,	,
cord-303183-oya0pdhw	15	27	given	give	VBN
cord-303183-oya0pdhw	15	28	the	the	DT
cord-303183-oya0pdhw	15	29	lack	lack	NN
cord-303183-oya0pdhw	15	30	of	of	IN
cord-303183-oya0pdhw	15	31	the	the	DT
cord-303183-oya0pdhw	15	32	true	true	JJ
cord-303183-oya0pdhw	15	33	denominator	denominator	NN
cord-303183-oya0pdhw	15	34	on	on	IN
cord-303183-oya0pdhw	15	35	which	which	WDT
cord-303183-oya0pdhw	15	36	COVID	covid	NN
cord-303183-oya0pdhw	15	37	-	-	HYPH
cord-303183-oya0pdhw	15	38	cases	case	NNS
cord-303183-oya0pdhw	15	39	were	be	VBD
cord-303183-oya0pdhw	15	40	reported	report	VBN
cord-303183-oya0pdhw	15	41	.	.	.
cord-303183-oya0pdhw	16	1	In	in	IN
cord-303183-oya0pdhw	16	2	the	the	DT
cord-303183-oya0pdhw	16	3	current	current	JJ
cord-303183-oya0pdhw	16	4	scenario	scenario	NN
cord-303183-oya0pdhw	16	5	,	,	,
cord-303183-oya0pdhw	16	6	the	the	DT
cord-303183-oya0pdhw	16	7	value	value	NN
cord-303183-oya0pdhw	16	8	of	of	IN
cord-303183-oya0pdhw	16	9	reliable	reliable	JJ
cord-303183-oya0pdhw	16	10	predictions	prediction	NNS
cord-303183-oya0pdhw	16	11	could	could	MD
cord-303183-oya0pdhw	16	12	be	be	VB
cord-303183-oya0pdhw	16	13	even	even	RB
cord-303183-oya0pdhw	16	14	more	more	RBR
cord-303183-oya0pdhw	16	15	important	important	JJ
cord-303183-oya0pdhw	16	16	in	in	IN
cord-303183-oya0pdhw	16	17	the	the	DT
cord-303183-oya0pdhw	16	18	lack	lack	NN
cord-303183-oya0pdhw	16	19	of	of	IN
cord-303183-oya0pdhw	16	20	prophylactic	prophylactic	JJ
cord-303183-oya0pdhw	16	21	solutions	solution	NNS
cord-303183-oya0pdhw	16	22	,	,	,
cord-303183-oya0pdhw	16	23	especially	especially	RB
cord-303183-oya0pdhw	16	24	in	in	IN
cord-303183-oya0pdhw	16	25	light	light	NN
cord-303183-oya0pdhw	16	26	of	of	IN
cord-303183-oya0pdhw	16	27	the	the	DT
cord-303183-oya0pdhw	16	28	fact	fact	NN
cord-303183-oya0pdhw	16	29	that	that	IN
cord-303183-oya0pdhw	16	30	the	the	DT
cord-303183-oya0pdhw	16	31	only	only	JJ
cord-303183-oya0pdhw	16	32	effective	effective	JJ
cord-303183-oya0pdhw	16	33	tool	tool	NN
cord-303183-oya0pdhw	16	34	applied	apply	VBN
cord-303183-oya0pdhw	16	35	until	until	IN
cord-303183-oya0pdhw	16	36	today	today	NN
cord-303183-oya0pdhw	16	37	was	be	VBD
cord-303183-oya0pdhw	16	38	social	social	JJ
cord-303183-oya0pdhw	16	39	distancing	distancing	NN
cord-303183-oya0pdhw	16	40	.	.	.
cord-303183-oya0pdhw	17	1	Reliable	reliable	JJ
cord-303183-oya0pdhw	17	2	predictions	prediction	NNS
cord-303183-oya0pdhw	17	3	of	of	IN
cord-303183-oya0pdhw	17	4	future	future	JJ
cord-303183-oya0pdhw	17	5	outbreaks	outbreak	NNS
cord-303183-oya0pdhw	17	6	,	,	,
cord-303183-oya0pdhw	17	7	of	of	IN
cord-303183-oya0pdhw	17	8	their	-PRON-	PRP$
cord-303183-oya0pdhw	17	9	setting	setting	NN
cord-303183-oya0pdhw	17	10	and	and	CC
cord-303183-oya0pdhw	17	11	extension	extension	NN
cord-303183-oya0pdhw	17	12	,	,	,
cord-303183-oya0pdhw	17	13	would	would	MD
cord-303183-oya0pdhw	17	14	be	be	VB
cord-303183-oya0pdhw	17	15	the	the	DT
cord-303183-oya0pdhw	17	16	only	only	JJ
cord-303183-oya0pdhw	17	17	tool	tool	NN
cord-303183-oya0pdhw	17	18	to	to	TO
cord-303183-oya0pdhw	17	19	prevent	prevent	VB
cord-303183-oya0pdhw	17	20	the	the	DT
cord-303183-oya0pdhw	17	21	evolution	evolution	NN
cord-303183-oya0pdhw	17	22	of	of	IN
cord-303183-oya0pdhw	17	23	events	event	NNS
cord-303183-oya0pdhw	17	24	in	in	IN
cord-303183-oya0pdhw	17	25	which	which	WDT
cord-303183-oya0pdhw	17	26	the	the	DT
cord-303183-oya0pdhw	17	27	world	world	NN
cord-303183-oya0pdhw	17	28	has	have	VBZ
cord-303183-oya0pdhw	17	29	stumbled	stumble	VBN
cord-303183-oya0pdhw	17	30	in	in	IN
cord-303183-oya0pdhw	17	31	the	the	DT
cord-303183-oya0pdhw	17	32	last	last	JJ
cord-303183-oya0pdhw	17	33	few	few	JJ
cord-303183-oya0pdhw	17	34	months	month	NNS
cord-303183-oya0pdhw	17	35	.	.	.
cord-303183-oya0pdhw	18	1	In	in	IN
cord-303183-oya0pdhw	18	2	the	the	DT
cord-303183-oya0pdhw	18	3	meantime	meantime	NN
cord-303183-oya0pdhw	18	4	,	,	,
cord-303183-oya0pdhw	18	5	the	the	DT
cord-303183-oya0pdhw	18	6	heartfelt	heartfelt	JJ
cord-303183-oya0pdhw	18	7	research	research	NN
cord-303183-oya0pdhw	18	8	of	of	IN
cord-303183-oya0pdhw	18	9	therapeutic	therapeutic	JJ
cord-303183-oya0pdhw	18	10	solutions	solution	NNS
cord-303183-oya0pdhw	18	11	remains	remain	VBZ
cord-303183-oya0pdhw	18	12	a	a	DT
cord-303183-oya0pdhw	18	13	mission	mission	NN
cord-303183-oya0pdhw	18	14	of	of	IN
cord-303183-oya0pdhw	18	15	physicians	physician	NNS
cord-303183-oya0pdhw	18	16	and	and	CC
cord-303183-oya0pdhw	18	17	researchers	researcher	NNS
cord-303183-oya0pdhw	18	18	of	of	IN
cord-303183-oya0pdhw	18	19	all	all	DT
cord-303183-oya0pdhw	18	20	branches	branch	NNS
cord-303183-oya0pdhw	18	21	,	,	,
cord-303183-oya0pdhw	18	22	sometimes	sometimes	RB
cord-303183-oya0pdhw	18	23	contributing	contribute	VBG
cord-303183-oya0pdhw	18	24	to	to	IN
cord-303183-oya0pdhw	18	25	creating	create	VBG
cord-303183-oya0pdhw	18	26	new	new	JJ
cord-303183-oya0pdhw	18	27	professional	professional	JJ
cord-303183-oya0pdhw	18	28	figures	figure	NNS
cord-303183-oya0pdhw	18	29	between	between	IN
cord-303183-oya0pdhw	18	30	immunology	immunology	NN
cord-303183-oya0pdhw	18	31	,	,	,
cord-303183-oya0pdhw	18	32	infectious	infectious	JJ
cord-303183-oya0pdhw	18	33	diseases	disease	NNS
cord-303183-oya0pdhw	18	34	and	and	CC
cord-303183-oya0pdhw	18	35	other	other	JJ
cord-303183-oya0pdhw	18	36	specialties	specialty	NNS
cord-303183-oya0pdhw	18	37	.	.	.
cord-303183-oya0pdhw	19	1	Because	because	IN
cord-303183-oya0pdhw	19	2	union	union	NN
cord-303183-oya0pdhw	19	3	is	be	VBZ
cord-303183-oya0pdhw	19	4	strength	strength	NN
cord-303183-oya0pdhw	19	5	(	(	-LRB-
cord-303183-oya0pdhw	19	6	Figure	figure	NN
cord-303183-oya0pdhw	19	7	1	1	CD
cord-303183-oya0pdhw	19	8	)	)	-RRB-
cord-303183-oya0pdhw	19	9	.	.	.
cord-303183-oya0pdhw	20	1	The	the	DT
cord-303183-oya0pdhw	20	2	author	author	NN
cord-303183-oya0pdhw	20	3	has	have	VBZ
cord-303183-oya0pdhw	20	4	no	no	DT
cord-303183-oya0pdhw	20	5	relevant	relevant	JJ
cord-303183-oya0pdhw	20	6	affiliations	affiliation	NNS
cord-303183-oya0pdhw	20	7	or	or	CC
cord-303183-oya0pdhw	20	8	financial	financial	JJ
cord-303183-oya0pdhw	20	9	involvement	involvement	NN
cord-303183-oya0pdhw	20	10	with	with	IN
cord-303183-oya0pdhw	20	11	any	any	DT
cord-303183-oya0pdhw	20	12	organization	organization	NN
cord-303183-oya0pdhw	20	13	or	or	CC
cord-303183-oya0pdhw	20	14	entity	entity	NN
cord-303183-oya0pdhw	20	15	with	with	IN
cord-303183-oya0pdhw	20	16	a	a	DT
cord-303183-oya0pdhw	20	17	financial	financial	JJ
cord-303183-oya0pdhw	20	18	interest	interest	NN
cord-303183-oya0pdhw	20	19	in	in	IN
cord-303183-oya0pdhw	20	20	or	or	CC
cord-303183-oya0pdhw	20	21	financial	financial	JJ
cord-303183-oya0pdhw	20	22	conflict	conflict	NN
cord-303183-oya0pdhw	20	23	with	with	IN
cord-303183-oya0pdhw	20	24	the	the	DT
cord-303183-oya0pdhw	20	25	subject	subject	JJ
cord-303183-oya0pdhw	20	26	matter	matter	NN
cord-303183-oya0pdhw	20	27	or	or	CC
cord-303183-oya0pdhw	20	28	materials	material	NNS
cord-303183-oya0pdhw	20	29	discussed	discuss	VBN
cord-303183-oya0pdhw	20	30	in	in	IN
cord-303183-oya0pdhw	20	31	the	the	DT
cord-303183-oya0pdhw	20	32	manuscript	manuscript	NN
cord-303183-oya0pdhw	20	33	.	.	.
cord-303183-oya0pdhw	21	1	This	this	DT
cord-303183-oya0pdhw	21	2	includes	include	VBZ
cord-303183-oya0pdhw	21	3	employment	employment	NN
cord-303183-oya0pdhw	21	4	,	,	,
cord-303183-oya0pdhw	21	5	consultancies	consultancy	NNS
cord-303183-oya0pdhw	21	6	,	,	,
cord-303183-oya0pdhw	21	7	honoraria	honorarium	NNS
cord-303183-oya0pdhw	21	8	,	,	,
cord-303183-oya0pdhw	21	9	stock	stock	NN
cord-303183-oya0pdhw	21	10	ownership	ownership	NN
cord-303183-oya0pdhw	21	11	or	or	CC
cord-303183-oya0pdhw	21	12	options	option	NNS
cord-303183-oya0pdhw	21	13	,	,	,
cord-303183-oya0pdhw	21	14	expert	expert	JJ
cord-303183-oya0pdhw	21	15	testimony	testimony	NN
cord-303183-oya0pdhw	21	16	,	,	,
cord-303183-oya0pdhw	21	17	grants	grant	NNS
cord-303183-oya0pdhw	21	18	or	or	CC
cord-303183-oya0pdhw	21	19	patents	patent	NNS
cord-303183-oya0pdhw	21	20	received	receive	VBN
cord-303183-oya0pdhw	21	21	or	or	CC
cord-303183-oya0pdhw	21	22	pending	pende	VBG
cord-303183-oya0pdhw	21	23	,	,	,
cord-303183-oya0pdhw	21	24	or	or	CC
cord-303183-oya0pdhw	21	25	royalties	royalty	NNS
cord-303183-oya0pdhw	21	26	.	.	.
cord-303183-oya0pdhw	22	1	No	no	DT
cord-303183-oya0pdhw	22	2	writing	writing	NN
cord-303183-oya0pdhw	22	3	assistance	assistance	NN
cord-303183-oya0pdhw	22	4	was	be	VBD
cord-303183-oya0pdhw	22	5	utilized	utilize	VBN
cord-303183-oya0pdhw	22	6	in	in	IN
cord-303183-oya0pdhw	22	7	the	the	DT
cord-303183-oya0pdhw	22	8	production	production	NN
cord-303183-oya0pdhw	22	9	of	of	IN
cord-303183-oya0pdhw	22	10	this	this	DT
cord-303183-oya0pdhw	22	11	manuscript	manuscript	NN
cord-303183-oya0pdhw	22	12	.	.	.
cord-303183-oya0pdhw	23	1	Recovery	recovery	NN
cord-303183-oya0pdhw	23	2	of	of	IN
cord-303183-oya0pdhw	23	3	COVID-19	covid-19	JJ
cord-303183-oya0pdhw	23	4	acute	acute	JJ
cord-303183-oya0pdhw	23	5	respiratory	respiratory	JJ
cord-303183-oya0pdhw	23	6	distress	distress	NN
cord-303183-oya0pdhw	23	7	syndrome	syndrome	NN
cord-303183-oya0pdhw	23	8	with	with	IN
cord-303183-oya0pdhw	23	9	tocilizumab	tocilizumab	NNP
cord-303183-oya0pdhw	23	10	:	:	:
cord-303183-oya0pdhw	23	11	successful	successful	JJ
cord-303183-oya0pdhw	23	12	outcome	outcome	NN
cord-303183-oya0pdhw	23	13	in	in	IN
cord-303183-oya0pdhw	23	14	two	two	CD
cord-303183-oya0pdhw	23	15	critically	critically	RB
cord-303183-oya0pdhw	23	16	ill	ill	JJ
cord-303183-oya0pdhw	23	17	patients	patient	NNS
cord-303183-oya0pdhw	23	18	How	how	WRB
cord-303183-oya0pdhw	23	19	COVID-19	COVID-19	NNP
cord-303183-oya0pdhw	23	20	affects	affect	VBZ
cord-303183-oya0pdhw	23	21	patients	patient	NNS
cord-303183-oya0pdhw	23	22	receiving	receive	VBG
cord-303183-oya0pdhw	23	23	anticytokine	anticytokine	NN
cord-303183-oya0pdhw	23	24	and	and	CC
cord-303183-oya0pdhw	23	25	JAK	JAK	NNP
cord-303183-oya0pdhw	23	26	inhibitors	inhibitor	NNS
cord-303183-oya0pdhw	23	27	in	in	IN
cord-303183-oya0pdhw	23	28	rheumatology	rheumatology	NN
cord-303183-oya0pdhw	23	29	and	and	CC
cord-303183-oya0pdhw	23	30	dermatology	dermatology	NN
cord-303183-oya0pdhw	23	31	Potential	potential	JJ
cord-303183-oya0pdhw	23	32	protective	protective	JJ
cord-303183-oya0pdhw	23	33	and	and	CC
cord-303183-oya0pdhw	23	34	therapeutic	therapeutic	JJ
cord-303183-oya0pdhw	23	35	role	role	NN
cord-303183-oya0pdhw	23	36	of	of	IN
cord-303183-oya0pdhw	23	37	immune	immune	JJ
cord-303183-oya0pdhw	23	38	checkpoint	checkpoint	NN
cord-303183-oya0pdhw	23	39	inhibitors	inhibitor	NNS
cord-303183-oya0pdhw	23	40	against	against	IN
cord-303183-oya0pdhw	23	41	viral	viral	JJ
cord-303183-oya0pdhw	23	42	infections	infection	NNS
cord-303183-oya0pdhw	23	43	and	and	CC
cord-303183-oya0pdhw	23	44	COVID-19	COVID-19	NNP
cord-303183-oya0pdhw	23	45	Clinical	clinical	JJ
cord-303183-oya0pdhw	23	46	impact	impact	NN
cord-303183-oya0pdhw	23	47	of	of	IN
cord-303183-oya0pdhw	23	48	COVID-19	COVID-19	NNP
cord-303183-oya0pdhw	23	49	in	in	IN
cord-303183-oya0pdhw	23	50	a	a	DT
cord-303183-oya0pdhw	23	51	single	single	JJ
cord-303183-oya0pdhw	23	52	-	-	HYPH
cord-303183-oya0pdhw	23	53	center	center	NN
cord-303183-oya0pdhw	23	54	cohort	cohort	NN
cord-303183-oya0pdhw	23	55	from	from	IN
cord-303183-oya0pdhw	23	56	a	a	DT
cord-303183-oya0pdhw	23	57	prospective	prospective	JJ
cord-303183-oya0pdhw	23	58	study	study	NN
cord-303183-oya0pdhw	23	59	on	on	IN
cord-303183-oya0pdhw	23	60	cancer	cancer	NN
cord-303183-oya0pdhw	23	61	patients	patient	NNS
cord-303183-oya0pdhw	23	62	receiving	receive	VBG
cord-303183-oya0pdhw	23	63	immunotherapy	immunotherapy	NN
cord-303183-oya0pdhw	23	64	COVID-19	covid-19	NN
cord-303183-oya0pdhw	23	65	in	in	IN
cord-303183-oya0pdhw	23	66	a	a	DT
cord-303183-oya0pdhw	23	67	patient	patient	NN
cord-303183-oya0pdhw	23	68	with	with	IN
cord-303183-oya0pdhw	23	69	advanced	advanced	JJ
cord-303183-oya0pdhw	23	70	merkel	merkel	NNP
cord-303183-oya0pdhw	23	71	cell	cell	NN
cord-303183-oya0pdhw	23	72	carcinoma	carcinoma	NN
cord-303183-oya0pdhw	23	73	receiving	receive	VBG
cord-303183-oya0pdhw	23	74	immunotherapy	immunotherapy	NN
cord-303183-oya0pdhw	23	75	Case	Case	NNP
cord-303183-oya0pdhw	23	76	report	report	NN
cord-303183-oya0pdhw	23	77	:	:	:
cord-303183-oya0pdhw	23	78	use	use	NN
cord-303183-oya0pdhw	23	79	of	of	IN
cord-303183-oya0pdhw	23	80	lenzilumab	lenzilumab	NNP
cord-303183-oya0pdhw	23	81	and	and	CC
cord-303183-oya0pdhw	23	82	tocilizumab	tocilizumab	NNP
cord-303183-oya0pdhw	23	83	for	for	IN
cord-303183-oya0pdhw	23	84	the	the	DT
cord-303183-oya0pdhw	23	85	treatment	treatment	NN
cord-303183-oya0pdhw	23	86	of	of	IN
cord-303183-oya0pdhw	23	87	coronavirus	coronavirus	NN
cord-303183-oya0pdhw	23	88	disease	disease	NN
cord-303183-oya0pdhw	23	89	2019	2019	CD
cord-303183-oya0pdhw	24	1	COVID-19	COVID-19	NNP
cord-303183-oya0pdhw	24	2	and	and	CC
cord-303183-oya0pdhw	24	3	immunotherapy	immunotherapy	NN
cord-303183-oya0pdhw	24	4	:	:	:
cord-303183-oya0pdhw	24	5	the	the	DT
cord-303183-oya0pdhw	24	6	complex	complex	JJ
cord-303183-oya0pdhw	24	7	relationship	relationship	NN
cord-303183-oya0pdhw	24	8	!	!	.
cord-303183-oya0pdhw	25	1	Immunotherapy	Immunotherapy	NNP
cord-303183-oya0pdhw	25	2	From	from	IN
cord-303183-oya0pdhw	25	3	targeting	target	VBG
cord-303183-oya0pdhw	25	4	the	the	DT
cord-303183-oya0pdhw	25	5	tumor	tumor	NN
cord-303183-oya0pdhw	25	6	to	to	IN
cord-303183-oya0pdhw	25	7	targeting	target	VBG
cord-303183-oya0pdhw	25	8	the	the	DT
cord-303183-oya0pdhw	25	9	immune	immune	JJ
cord-303183-oya0pdhw	25	10	system	system	NN
cord-303183-oya0pdhw	25	11	:	:	:
cord-303183-oya0pdhw	25	12	transversal	transversal	JJ
cord-303183-oya0pdhw	25	13	challenges	challenge	NNS
cord-303183-oya0pdhw	25	14	in	in	IN
cord-303183-oya0pdhw	25	15	oncology	oncology	NN
cord-303183-oya0pdhw	25	16	with	with	IN
cord-303183-oya0pdhw	25	17	the	the	DT
cord-303183-oya0pdhw	25	18	inhibition	inhibition	NN
cord-303183-oya0pdhw	25	19	of	of	IN
cord-303183-oya0pdhw	25	20	the	the	DT
cord-303183-oya0pdhw	25	21	PD-1	PD-1	NNP
cord-303183-oya0pdhw	25	22	/	/	SYM
cord-303183-oya0pdhw	25	23	PD	PD	NNP
cord-303183-oya0pdhw	25	24	-	-	HYPH
cord-303183-oya0pdhw	25	25	L1	L1	NNP
cord-303183-oya0pdhw	25	26	axis	axis	NN
cord-303183-oya0pdhw	26	1	A	a	DT
cord-303183-oya0pdhw	26	2	paradigm	paradigm	NN
cord-303183-oya0pdhw	26	3	shift	shift	NN
cord-303183-oya0pdhw	26	4	in	in	IN
cord-303183-oya0pdhw	26	5	cancer	cancer	NN
cord-303183-oya0pdhw	26	6	immunotherapy	immunotherapy	NN
cord-303183-oya0pdhw	26	7	:	:	:
cord-303183-oya0pdhw	26	8	from	from	IN
cord-303183-oya0pdhw	26	9	enhancement	enhancement	NN
cord-303183-oya0pdhw	26	10	to	to	IN
cord-303183-oya0pdhw	26	11	normalization	normalization	NN
cord-303183-oya0pdhw	26	12	Guidance	guidance	NN
cord-303183-oya0pdhw	26	13	for	for	IN
cord-303183-oya0pdhw	26	14	the	the	DT
cord-303183-oya0pdhw	26	15	management	management	NN
cord-303183-oya0pdhw	26	16	of	of	IN
cord-303183-oya0pdhw	26	17	patients	patient	NNS
cord-303183-oya0pdhw	26	18	with	with	IN
cord-303183-oya0pdhw	26	19	vascular	vascular	JJ
cord-303183-oya0pdhw	26	20	disease	disease	NN
cord-303183-oya0pdhw	26	21	or	or	CC
cord-303183-oya0pdhw	26	22	cardiovascular	cardiovascular	JJ
cord-303183-oya0pdhw	26	23	risk	risk	NN
cord-303183-oya0pdhw	26	24	factors	factor	NNS
cord-303183-oya0pdhw	26	25	and	and	CC
cord-303183-oya0pdhw	26	26	COVID-19	covid-19	NN
cord-303183-oya0pdhw	26	27	:	:	:
cord-303183-oya0pdhw	26	28	position	position	NN
cord-303183-oya0pdhw	26	29	paper	paper	NN
cord-303183-oya0pdhw	26	30	from	from	IN
cord-303183-oya0pdhw	26	31	VAS	VAS	NNP
cord-303183-oya0pdhw	26	32	-	-	HYPH
cord-303183-oya0pdhw	26	33	European	European	NNP
cord-303183-oya0pdhw	26	34	Independent	Independent	NNP
cord-303183-oya0pdhw	26	35	Foundation	Foundation	NNP
cord-303183-oya0pdhw	26	36	in	in	IN
cord-303183-oya0pdhw	26	37	Angiology	Angiology	NNP
cord-303183-oya0pdhw	26	38	/	/	SYM
cord-303183-oya0pdhw	26	39	Vascular	Vascular	NNP
cord-303183-oya0pdhw	26	40	Medicine	Medicine	NNP